@article{oai:tsukuba.repo.nii.ac.jp:00045062,
 author = {Homma, Masato and 大河内, 信弘 and 本間, 真人 and 平野, 俊彦 and 湯沢, 賢治 and 大河内, 信弘 and 剣持, 敬},
 issue = {1},
 journal = {Organ Biology},
 month = {Mar},
 note = {Questionnaire survey concerning practical use of generic immunosuppressive agents and the European Society for Organ Transplantation (ESOT) guideline was conducted in 130 clinical institutions including transplant hospitals where the members of The Japan Society for Organ Preservation and Biology were working. Forty five institutions answered the questionnaire survey (the recovery rate: 34.6%). Use of generic immunosuppressive agents in the institutions has been different among the agents; tacrolimus (6.7%), cyclosporin (8.9%) and mycophenorate mofetil (8.9%) and corticosteroid injection (51.1%). The results indicated that use of generic immunosuppressive agents, especially in the agents that require therapeutic drug monitoring (TDM) for dose adjustment, have not been spread in Japan. The most of the institutions (greater than 62%) agreed with the ESOT guideline for generic substitution of immunosuppressive agents. It is considered that the Japanese guideline is also required to prepare according to ESOT guideline, though the use of generic products have not been popular yet Japan.},
 pages = {76--80},
 title = {免疫抑制薬の後発医薬品使用の実態：アンケート調査報告},
 volume = {24},
 year = {2017},
 yomi = {ホンマ, マサト and オオコウチ, ノブヒロ}
}